New York State Common Retirement Fund Boosts Holdings in Integer Holdings Co. (NYSE:ITGR)

New York State Common Retirement Fund raised its holdings in Integer Holdings Co. (NYSE:ITGR) by 20.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 232,569 shares of the medical equipment provider’s stock after purchasing an additional 40,158 shares during the period. New York State Common Retirement Fund owned 0.69% of Integer worth $30,820,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of ITGR. Geode Capital Management LLC boosted its position in shares of Integer by 1.2% in the third quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock valued at $99,408,000 after acquiring an additional 9,421 shares during the period. Loomis Sayles & Co. L P boosted its position in shares of Integer by 3.0% in the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock valued at $69,943,000 after acquiring an additional 15,446 shares during the period. Congress Asset Management Co. boosted its position in shares of Integer by 2.0% in the fourth quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider’s stock valued at $66,041,000 after acquiring an additional 9,565 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of Integer by 1.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 404,029 shares of the medical equipment provider’s stock valued at $52,524,000 after acquiring an additional 4,946 shares during the period. Finally, Lord Abbett & CO. LLC boosted its position in shares of Integer by 3.5% in the third quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock valued at $37,716,000 after acquiring an additional 9,754 shares during the period. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Trading Down 5.1 %

Shares of ITGR opened at $135.91 on Friday. The firm has a market cap of $4.56 billion, a price-to-earnings ratio of 41.95, a PEG ratio of 1.80 and a beta of 1.13. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. Integer Holdings Co. has a fifty-two week low of $97.49 and a fifty-two week high of $146.36. The firm has a 50 day moving average price of $137.98 and a 200-day moving average price of $132.28.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a return on equity of 11.63% and a net margin of 6.70%. As a group, equities research analysts forecast that Integer Holdings Co. will post 5.33 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on ITGR shares. KeyCorp lifted their target price on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Wells Fargo & Company reiterated an “overweight” rating and set a $160.00 target price on shares of Integer in a research report on Tuesday, December 3rd. Piper Sandler reiterated an “overweight” rating and set a $140.00 target price (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Citigroup lifted their target price on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, December 11th. Finally, Truist Financial lifted their target price on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, Integer has a consensus rating of “Moderate Buy” and a consensus price target of $146.56.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.